Article
Cadmium activation of wild-type and constitutively active estrogen receptor alpha.
Frontiers in endocrinology - 1 Jan 2024
Psaltis John B, Wang Qiaochu, Yan Gai, Gahtani Reem, Huang Nanxi, Haddad Bassem R, Martin Mary Beth
Abstract excerpt
The estrogen receptor alpha (ERα) plays a central role in the etiology, progression, and treatment of breast cancers. Constitutively activating somatic mutations Y537S and D538G, in the ligand binding domain (LBD) of ESR1, are associated with acquired resistance to endocrine therapies. We have previously shown that the metalloestrogen calcium activates ERα through an interaction with the LBD of the receptor. This...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
